miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's Disease.

MLA

Wang, Long, et al. “MiR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease.” International Journal of Molecular Sciences, vol. 23, no. 14, July 2022. EBSCOhost, https://doi.org/10.3390/ijms23147992.

APA

Wang, L., Shui, X., Mei, Y., Xia, Y., Lan, G., Hu, L., Zhang, M., Gan, C.-L., Li, R., Tian, Y., Wang, Q., Gu, X., Chen, D., Zhang, T., & Lee, T. H. (2022). miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease. International Journal of Molecular Sciences, 23(14). https://doi.org/10.3390/ijms23147992

Chicago

Wang, Long, Xindong Shui, Yingxue Mei, Yongfang Xia, Guihua Lan, Li Hu, Mi Zhang, et al. 2022. “MiR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease.” International Journal of Molecular Sciences 23 (14). doi:10.3390/ijms23147992.